RayzeBio, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
RayzeBio, Inc.
CIK #0001825367
EDGAR Form CIK 2011 - 2025
10-Q [0001825367]
3 [0001825367]
4 [0001825367]
8-K [0001825367]
D [0001825367]
SC 13G [0001825367]
Form 13D/13G Filer Form 13D/13G Subject Filed
venBio Global Strategic Fund III LP Rayzebio Inc [2024-02-09]
Versant Venture Capital VII LP Rayzebio Inc [2024-02-08]
Wellington Management Group LLP Rayzebio Inc [2024-02-08]
Venrock Healthcare Capital Partners III LP Rayzebio Inc [2023-09-29]
Viking Global Investors LP Rayzebio Inc [2023-09-21]
Form 3/4/5 Subject 2011 - 2025
Viking Global Opportunities Parent GP LLC
Halvorsen Ole Andreas
Viking Global Opportunities Drawdown GP LLC
Ott David C.
RayzeBio, Inc.
Shabet Rose Sharon
Viking Global Opportunities Drawdown (Aggregator) LP
Viking Global Opportunities Drawdown Portfolio GP LLC
Viking Global Investors LP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities GP LLC
Kush Arvind
Song Kenneth
Katabi Maha
Moran Susan
Oliger Christy J.
You Angie
Van Hauwermeiren Timothy
Tagliaferri Mary
Heyman Richard A.
Larson Yi
Goodman Corey S
venBio Global Strategic GP III Ltd
venBio Global Strategic Fund III, L.P.
Adelman Robert J
venBio Global Strategic GP III LP
Redmile Biopharma Investments II, L.P.
Redmile Group, LLC
Green Jeremy
Wellington Biomedical Innovation Master Investors (Cayman) I
Royston Aaron
Versant Ventures VII GP, L.P.
Versant Vantage I GP-GP, LLC
Versant Ventures VII GP-GP, LLC
Versant Venture Capital VII, L.P.
Versant Vantage I GP, L.P.
Versant Vantage I, L.P.
Terms | Privacy | Guide
tony@aum13f.com